Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregor Hutter

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Leukemia|September 4, 2021
Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacySime Brkic, Simona Stivala, Alice Santopolo, et al.
Science Translational Medicine|July 19, 2023
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastomaPhilip Schmassmann, Julien Roux, Alicia Buck, et al.
Neurosurgery|July 31, 2015
Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor CellsSiddhartha S Mitra, Abdullah H Feroze, Sharareh Gholamin, et al.
Plos One|April 20, 2016
Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In VivoMichael Zhang, Gregor Hutter, Suzana A Kahn, et al.
Developmental Cell|July 8, 2022
Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cellsElena Parmigiani, Robert Ivanek, Chiara Rolando, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2019
Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastomaGregor Hutter, Johanna Theruvath, Claus Moritz Graef, et al.
Nature Communications|May 22, 2025
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastomaMichal Beffinger, Linda Schellhammer, Betül Taskoparan, et al.
Science Advances|July 1, 2022
Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not peripheryTala Shekarian, Carl P Zinner, Ewelina M Bartoszek, et al.
Nature Communications|October 10, 2018
Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastomaSuzana A Kahn, Xin Wang, Ryan T Nitta, et al.
Nature Communications|November 9, 2024
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blockerTomás A Martins, Deniz Kaymak, Nazanin Tatari, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Leukemia|September 4, 2021
Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacySime Brkic, Simona Stivala, Alice Santopolo, et al.
Science Translational Medicine|July 19, 2023
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastomaPhilip Schmassmann, Julien Roux, Alicia Buck, et al.
Neurosurgery|July 31, 2015
Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor CellsSiddhartha S Mitra, Abdullah H Feroze, Sharareh Gholamin, et al.
Plos One|April 20, 2016
Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In VivoMichael Zhang, Gregor Hutter, Suzana A Kahn, et al.
Developmental Cell|July 8, 2022
Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cellsElena Parmigiani, Robert Ivanek, Chiara Rolando, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2019
Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastomaGregor Hutter, Johanna Theruvath, Claus Moritz Graef, et al.
Nature Communications|May 22, 2025
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastomaMichal Beffinger, Linda Schellhammer, Betül Taskoparan, et al.
Science Advances|July 1, 2022
Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not peripheryTala Shekarian, Carl P Zinner, Ewelina M Bartoszek, et al.
Nature Communications|October 10, 2018
Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastomaSuzana A Kahn, Xin Wang, Ryan T Nitta, et al.
Nature Communications|November 9, 2024
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blockerTomás A Martins, Deniz Kaymak, Nazanin Tatari, et al.
Pageof 6